Literature DB >> 31149087

UPDATING THE CONCEPT OF METABOLICALLY HEALTHY OBESITY.

C Bala1, A-E Craciun1, N Hancu1.   

Abstract

Obesity is a well-recognized risk factor for type 2 diabetes, cardiovascular disease, and several types of cancer. However, a proportion of the obese individuals display a significantly lower risk for metabolic complications than expected for their degree of body mass index, and this subtype of obesity was described as "metabolically healthy obesity" (MHO). No universally accepted criteria for the diagnosis of MHO exists and the prevalence of this subtype of obesity varies largely according to criteria used. Broadly, MHO is characterized by a lower amount of visceral fat, a more favorable inflammatory profile, and less insulin resistance as compared to the metabolically unhealthy obesity. Currently, controversies exist regarding the risk of cardiovascular events and all-cause mortality associated with MHO as compared to metabolically-healthy non-obese individuals. Further research is needed in order to identify the MHO phenotype and if MHO is truly healthy for a long period of time or if it is a transient state from normal metabolic/normal weight to abnormal metabolic/obese state. This review will discuss the MHO definition criteria; the differences between MHO and metabolically unhealthy obesity; the possible underlying mechanisms and clinical implications of MHO.

Entities:  

Keywords:  inflammation; insulin resistance; metabolically healthy obesity; obesity; visceral adipose tissue

Year:  2016        PMID: 31149087      PMCID: PMC6535297          DOI: 10.4183/aeb.2016.197

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  8 in total

1.  METABOLOMIC ANALYSIS OF NORMAL WEIGHT, HEALTHY AND UNHEALTHY OBESITY: AMINO ACID CHANGE ACROSS THE SPECTRUM OF METABOLIC WELLBEING IN WOMEN.

Authors:  A A Muresan; A Rusu; G Roman; C Bala
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

2.  THE IN VITRO CYTOTOXICITY, GENOTOXICITY AND OXIDATIVE DAMAGE POTENTIAL OF THE ORAL DIPEPTIDYL PEPTIDASE-4 INHIBITOR, LINAGLIPTIN, ON CULTURED HUMAN MONONUCLEAR BLOOD CELLS.

Authors:  K Çadirci; H Türkez; Ö Özdemir
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jan-Mar       Impact factor: 0.877

3.  HORMONAL REGULATION OF CARBOHYDRATE AND FAT METABOLISM IN WOMEN WITH DIFFERENT OBESITY TYPES IN THE FOOD DEPRIVATION TEST.

Authors:  B B Pinkhasov; V G Selyatitskaya; D A Deev; O I Kuzminova; E L Astrakhantseva
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jul-Sep       Impact factor: 0.877

4.  A Novel Subset of CD95+ Pro-Inflammatory Macrophages Overcome miR155 Deficiency and May Serve as a Switch From Metabolically Healthy Obesity to Metabolically Unhealthy Obesity.

Authors:  Candice Johnson; Charles Drummer Iv; Huimin Shan; Ying Shao; Yu Sun; Yifan Lu; Fatma Saaoud; Keman Xu; Gayani Nanayakkara; Pu Fang; Zsolt Bagi; Xiaohua Jiang; Eric T Choi; Hong Wang; Xiaofeng Yang
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

5.  Identification of adipose tissue-related predictors of the reduction in cardiovascular risk induced by metabolic surgery.

Authors:  Alberto Melchor-López; Juan Antonio Suárez-Cuenca; Diana Zaineff Banderas-Lares; Gustavo De la Peña-Sosa; Moisés Salamanca-García; Eduardo Vera-Gómez; Alejandro Hernández-Patricio; Juan Ariel Gutiérrez-Buendía; Carlos Ramiro Zamora-Alemán; Sofía Lizeth Alcaráz-Estrada; Moisés Ortiz-Fernández; Jesús Montoya-Ramírez; Omar Felipe Gaytán-Fuentes; Rebeca Pérez-Cabeza de Vaca; Mónica Escamilla-Tilch; Juan Antonio Pineda-Juárez; Mario Antonio Téllez-González; Paul Mondragón-Terán; Martha Eunice Rodríguez-Arellano; Alejandra Contreras-Ramos; Silvia García; Rolando Efraín Hernández-Muñoz
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

6.  Causal relationship of excess body weight on cardiovascular events through risk factors.

Authors:  Thosaphol Limpijankit; Prin Vathesatogkit; Dujrudee Matchariyakul; Sirichai Wiriyatanakorn; Sukanya Siriyotha; Ammarin Thakkinstian; Piyamitr Sritara
Journal:  Sci Rep       Date:  2022-03-28       Impact factor: 4.379

7.  The Association Between Hyperuricemia and Obesity Metabolic Phenotypes in Chinese General Population: A Retrospective Analysis.

Authors:  Xiaojing Feng; Yanyi Yang; Huiqi Xie; Siqi Zhuang; Yiyuan Fang; Yufeng Dai; Ping Jiang; Hongzhi Chen; Haoneng Tang; Lingli Tang
Journal:  Front Nutr       Date:  2022-04-18

8.  Assessment of fatty liver and its correlation with glycemic control in patients with type 2 diabetes mellitus attending Dessie Comprehensive Specialized Hospital, Northeast Ethiopia.

Authors:  Gashaw Abebe; Daniel Ayanaw; Tiget Ayelgn Mengstie; Gashaw Dessie; Tabarak Malik
Journal:  SAGE Open Med       Date:  2022-09-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.